Aclarion

Yahoo Finance • 13 days ago

Auddia Announces Non-binding Letter of Intent for Business Combination and Restructuring

Restructuring into a holding company focused on delivering AI and web3 efficiencies to portfolio companies AI efficiencies include discounted AI compute costs, centralized AI model training and engineering, and utilization of AI tools to... Full story

Yahoo Finance • 13 days ago

Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts

Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume growth for the first time and expects co... Full story

Yahoo Finance • 2 months ago

Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery

(RTTNews) - Aclarion, Inc. (ACON), a healthcare technology firm, has announced the enrollment of the first patient in its CLARITY trial. The study aims to evaluate the clinical and economic value of its Nociscan platform in spine surgerie... Full story

Yahoo Finance • 2 months ago

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

BROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (Aclarion or the Company) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to... Full story

Yahoo Finance • 5 months ago

Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments

PALM BEACH, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 bill... Full story

Yahoo Finance • 6 months ago

Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday?

Aclarion, Inc. (NASDAQ:ACON) shares are trading higher premarket on Monday after the company disclosed a commercial partnership with Scripps Health in San Diego, CA. This agreement will introduce Nociscan to Southern California and to the... Full story

Yahoo Finance • 6 months ago

Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders

BROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ACONW),ahealthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligen... Full story

Yahoo Finance • 2 years ago

Aclarion Presents at the NIH HEAL Initiative Fall Meeting

The Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, is funding ground-breaking low back pain research. The Back Pain Consortium (BACPAC) Research Program, a recipient of the NIH HEAL Initiative, is an effort to ad... Full story

Yahoo Finance • 2 years ago

Aclarion Provides Updated Investor Presentation and Corporate Update

Aclarion is steadily executing on a proven path toward standard of care. Ten prominent Key Opinion Leader (KOL) surgeons have formally engaged to partner with the company to drive market traction and reimbursement. Company is poised to r... Full story

Yahoo Finance • 3 years ago

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

NociscanTM is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological pain. Nociscan provides decision support to help bridge a major diagnostic void. Robert Eastlack, MD will... Full story